KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) FCF Margin (2016 - 2026)

Gilead Sciences filings provide 17 years of FCF Margin readings, the most recent being 39.39% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 203.0% to 39.39% in Q4 2025 year-over-year; TTM through Dec 2025 was 32.12%, a 372.0% decrease, with the full-year FY2025 number at 32.12%, down 372.0% from a year prior.
  • FCF Margin hit 39.39% in Q4 2025 for Gilead Sciences, down from 50.98% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 55.24% in Q3 2024 to a low of 10.17% in Q2 2025.
  • Median FCF Margin over the past 5 years was 32.81% (2023), compared with a mean of 32.76%.
  • The widest YoY moves for FCF Margin: up 3208bps in 2024, down -1614bps in 2024.
  • Gilead Sciences' FCF Margin stood at 42.09% in 2021, then decreased by -23bps to 32.29% in 2022, then fell by -15bps to 27.47% in 2023, then skyrocketed by 36bps to 37.36% in 2024, then grew by 5bps to 39.39% in 2025.
  • The last three reported values for FCF Margin were 39.39% (Q4 2025), 50.98% (Q3 2025), and 10.17% (Q2 2025) per Business Quant data.